How much revenue does the ambulatory cardiac monitoring devices market generate?

In 2027 the market for ambulatory cardiac monitoring devices is valued at USD 9.42 billion.

How much is the ambulatory cardiac monitoring devices industry expected to grow by 2036?

Ambulatory Cardiac Monitoring Devices Market size was estimated at USD 8.7 billion in 2026 and is projected to grow at a 9.88% CAGR from 2027 to 2036, reaching USD 22.32 billion by 2036.

How is the rising burden of cardiac disorders influencing ambulatory monitoring adoption?

Increasing prevalence of cardiac conditions is driving clinicians toward continuous ambulatory monitoring to capture intermittent symptoms missed in short diagnostic windows, expanding use of Holter, patch, and event-based devices in outpatient care pathways.

How is remote patient monitoring reshaping procurement of cardiac monitoring devices?

RPM programs are increasing demand for connected telemetry systems that transmit near real-time cardiac data, enabling faster triage and structured chronic care workflows, pushing adoption of integrated monitoring platforms and data-driven follow-up models.

Why do hospitals account for the largest share of the ambulatory cardiac monitoring devices market?

Hospitals held a 53.03% market share in 2026 due to their concentration of cardiology expertise, established monitoring workflows, and ongoing demand for structured cardiac assessment and follow-up care.

What is driving the growth of mobile cardiac telemetry in the ambulatory cardiac monitoring devices market?

Mobile cardiac telemetry is the fastest-growing device type because it enables responsive, continuous monitoring and captures irregular cardiac events that may be missed during shorter monitoring periods.

What supports North America’s leadership in ambulatory cardiac monitoring devices?

North America held a 45.37% share in 2026, supported by established cardiac care pathways and widespread integration of wearable monitoring into clinical practice.

Where is the fastest growth emerging in the ambulatory cardiac monitoring devices market?

Asia Pacific is expected to expand at an 11.65% CAGR, driven by mobile diagnostics adoption and broader access to outpatient cardiac monitoring.

What are the prominent companies operating in the ambulatory cardiac monitoring devices landscape?

Key players in the ambulatory cardiac monitoring devices market include Abbott Laboratories (United States), iRhythm Technologies, Inc. (United States), GE HealthCare Technologies Inc. (United States), Biotronik SE & Co. KG (Germany), Nihon Kohden Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (United States), ZOLL Medical Corporation (United States), Fukuda Denshi Co., Ltd. (Japan), Baxter International Inc. (Hill-Rom Holdings, Inc.) (United States).